Tzeng-huey Yang
Yilan, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Survival impact of hepatitis C virus eradication in patients with or without active hepatocellular carcinoma: A nationwide cohort study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 03, 2025
Incidences of Virological and Clinical Relapses After Cessation of Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate, or Entecavir in Patients With HBeAg-Negative Chronic Hepatitis B.
Journal: Journal of gastroenterology and hepatology
Published: December 30, 2024
Hepatitis B core-related antigen dynamics and risk of subsequent clinical relapses after nucleos(t)ide analog cessation.
Journal: Clinical and molecular hepatology
Published: June 05, 2023
Combining hepatitis B core-related and surface antigens at end of nucleos(t)ide analogue treatment to predict off-therapy relapse risk.
Journal: Alimentary pharmacology & therapeutics
Published: September 08, 2018
Time-varying serum gradient of hepatitis B surface antigen predicts risk of relapses after off-NA therapy.
Journal: BMC gastroenterology
Published: February 07, 2017
Serum viral load at the virological relapse predicts subsequent clinical flares in chronic hepatitis B patients off entecavir therapy.
Journal: Journal of gastroenterology and hepatology
Published: November 24, 2016
Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen-Negative Patients.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: December 28, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026